Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 20 filings·Updated 10 Jul 2026
Showing 10 of 20 filings.
10 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Demat/remat processing confirmed, securities listed, certificates mutilated/cancelled, and owner updated

Dematerialisation status

  • Dematerialisation/rematerialisation requests processed within 15 days of receipt.
  • Securities dematerialised/rematerialised listed on the exchanges where they are listed.
  • Physical share certificates for dematerialisation mutilated and cancelled after verification.
  • Depository's name substituted as registered owner for approved demat requests within the prescribed timeline.
Filed 19:57View Source
9 Jul 20261 filing
Company UpdateNewspaper Publication

Newspaper Publication regarding Special window for re-lodgement of transfer and dematerialisation request(s) of Physical securities

Filed 16:54View Source
26 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

Intimation of Closure of Trading Window

Filed 12:42View Source
16 Mar 20261 filing
Company UpdateNewspaper Publication

Newspaper Publication regarding special window for re-lodgement of transfer and dematerialisation request(s) of physical securities

Filed 12:49View Source
10 Mar 20262 filings
Company UpdateChange in Management

Ganga Pharmaceuticals Ltd - 539680 - Announcement under Regulation 30 (LODR)-Change in Management

Management Appointment and Re-appointment

  • Mr. Bharat Brijmohan Sharma re-appointed as Managing Director effective April 1, 2026, for three years.
  • Mr. Sharma is not liable to retire by rotation; re-appointment subject to Members' approval.
  • Mr. Sharma has over 35 years of experience in business and pharmaceutical industry.
  • Mrs. Bharat B. Sharma is spouse of Mrs. Srijna Sharma, Whole-time Director of the Company.
  • No regulatory authority has barred Mr. Sharma from holding Director office.
Filed 16:59View Source
Company UpdateChange in Directorate

Ganga Pharmaceuticals Ltd - 539680 - Announcement under Regulation 30 (LODR)-Change in Directorate

Board Appointment ️

  • Re-appointment of Mr. Bharat Brijmohan Sharma as Managing Director for three years from April 1, 2026, subject to Members' approval.
  • Mr. Sharma is not liable to retire by rotation.
  • Mr. Sharma has over 35 years of experience in business and pharmaceutical industry.
  • Mr. Sharma is not debarred from holding office by SEBI or other authorities.

Relationships

  • Mrs. Bharat B. Sharma is spouse of Mrs. Srijna Sharma, Whole-time Director of the Company.
Filed 16:51View Source
13 Jan 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulation , 2018 for the quarter ended December 31, 2025

Filed 18:09View Source
7 Nov 20252 filings
Company UpdateReg. 32 (1), (3) - Statement of Deviation & Variation

Statement of Deviation or Variation for the half year ended September 30, 2025

Filed 19:27View Source
Company UpdateReg. 32 (1), (3) - Statement of Deviation & Variation

Statement of Deviation or Variation for the half year ended September 30, 2025

Filed 17:21View Source
9 Oct 20251 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025

Filed 13:37View Source
Showing 10 of 20 filings